2022
DOI: 10.1016/j.jddst.2022.103764
|View full text |Cite
|
Sign up to set email alerts
|

Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 109 publications
0
6
0
Order By: Relevance
“…They may disrupt viral envelopes, rendering the viruses non-infectious. Biosurfactants could also interfere with viral entry into host cells or disrupt viral particles, inhibiting their infection ability (Sarangi et al,2022;Raza et al, 2023).…”
Section: Antiviral Propertiesmentioning
confidence: 99%
“…They may disrupt viral envelopes, rendering the viruses non-infectious. Biosurfactants could also interfere with viral entry into host cells or disrupt viral particles, inhibiting their infection ability (Sarangi et al,2022;Raza et al, 2023).…”
Section: Antiviral Propertiesmentioning
confidence: 99%
“…This is achieved through the creation of channels for ions. This process intensifies at higher surfactant concentrations, leading to disturbances in the membrane system [ 98 ]. Under specific conditions, biosurfactants have showcased their potential in inactivating a range of viruses, including herpes viruses, retroviruses, and other enveloped RNA or DNA viruses.…”
Section: Application Of Biosurfactants In Medical Sciencesmentioning
confidence: 99%
“…With Covid-19 infection, a healthy immune system entirely eradicates the virus without the patient displaying any symptoms. By inducing or activating immune cells such as macrophage, neutrophils, B cells and T cells, which deals with the production and memory storage of viral specific antibodies for recurrent infections, an effective adaptive immune response can be produced [120] . For example, inducing T cells facilitate the differentiation B cells into memory cells and plasma cells producing viral specific antibodies for recurrent infections [121] .…”
Section: Biosurfactants: Approach Toward Prevention and Management Of...mentioning
confidence: 99%
“…Some of the studies reported earlier revealed role of BSs along with bioactive peptides for inactivation of encapsulated viruses. For example, the biopeptide cyclosporine A, produced by the fungus Tolypocladium inflatum , apparently impeded the influenza viruses’ life cycle by preventing or delaying viral assembly following the synthesis of protein [120] . It was formerly thought that focusing on viral life cycle may be helpful in addressing antiviral drug resistance thereby liming the disease propagation.…”
Section: Biosurfactants: Approach Toward Prevention and Management Of...mentioning
confidence: 99%